Insider Buying: Intermolecular Inc. (IMI) Major Shareholder Buys 990,452 Shares of Stock
Intermolecular Inc. (NASDAQ:IMI) major shareholder William C. Martin acquired 990,452 shares of Intermolecular stock in a transaction on Thursday, November 17th. The stock was purchased at an average cost of $0.85 per share, with a total value of $841,884.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
Intermolecular Inc. (NASDAQ:IMI) opened at 1.01 on Friday. The firm has a 50-day moving average of $0.96 and a 200-day moving average of $1.34. Intermolecular Inc. has a 1-year low of $0.78 and a 1-year high of $2.92. The stock’s market capitalization is $50.02 million.
Several large investors have recently bought and sold shares of the company. Symmetry Peak Management LLC bought a new stake in Intermolecular during the third quarter valued at approximately $1,010,000. Vanguard Group Inc. boosted its position in shares of Intermolecular by 10.2% in the second quarter. Vanguard Group Inc. now owns 657,454 shares of the company’s stock worth $973,000 after buying an additional 61,000 shares during the period. Bridgeway Capital Management Inc. boosted its position in shares of Intermolecular by 12.9% in the second quarter. Bridgeway Capital Management Inc. now owns 392,500 shares of the company’s stock worth $581,000 after buying an additional 44,900 shares during the period. Finally, Spark Investment Management LLC boosted its position in shares of Intermolecular by 55.9% in the third quarter. Spark Investment Management LLC now owns 104,000 shares of the company’s stock worth $103,000 after buying an additional 37,300 shares during the period. 35.18% of the stock is owned by hedge funds and other institutional investors.
Intermolecular Company Profile
Intermolecular, Inc provides thin film solutions. The Company’s high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems.
Receive News & Stock Ratings for Intermolecular Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular Inc. and related stocks with our FREE daily email newsletter.